Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
This is a Keras plc bulletin board, not a meeting with my personal financial adviser. Debate the share and mind your own f**king business.
If you don't want it to be mine or anyone else's business then don't post your alleged f**king shareholding and average prices and brag about making a profit.
My personal position is irrelevant to what is going in for Keras plc and decisions going forward now.
Your insistence on not discussing Keras plc, the balanced pros and cons of Diamond Creek and focusing on my personal investment is weird. Are you weird Jim?
Yes, Keras owes me nothing - it doesn't mean I want to see it worth nothing. It also doesn't mean that I'm going to stop looking at the bigger picture of the company acquiring quick cash flow projects.
So focus on what's important. Keras plc.
I may be weird. Ask the wife, she'd probably agree.
However. What is weird is posting on a share BB about how many shares you allegedly bought, at what price you bought them, then denying you said it or paid that amount when reminded of it. All the while posting nothing but supportive conjecture of the company and it's prospects no matter what actually happens, or doesn't.
That makes you a liar. Or a blatant 'ramper'. Or both. Either way - nothing else you have to say is of any interest to me.
Or maybe you just don't read or engage in discussion around posts, you just jump into personal conjecture.
If you actually read posts, you'd see I'm not supportive at all costs. I wouldn't have invested in Keras plc as a standalone company post Calidus divestiture, but I'm in it now. As a 10 year old explorer with iron ore failures behind it, it faces a unique position in the market. It's broadly Nayega or bust. Diamond Creek is a bar job to help get us there. Or not, but we have a better chance of not adding to the litany of failed juniors with it than without it.
Openly discussing all sides of a conversation about a commonly held project is healthy. Certainly healthier than obsessing about another person's finances.
If you don't see how many times I refer to this company's potential liquidation and failure - that's on you, not me. I've had a career working with stricken companies and so appreciate what options may or may not be viable.
To head off your likely immediate response that I guess will again revolve around my personal finances rather than the company, no, I didn't invest in the Diamond Creek share issue. That diluted my position.
I do however, understand why it was the option taken, (and why the issue was fully subscribed).
I told you. I'm not interested. Save it for anyone else you think may be.
You aren't 'openly' discussing things when you try and deny what you've previously posted. You're now also claiming to know how much friends and family members of the BOD have invested.
Something very definitely weird about that and your claims, Mark. Now jog on and leave me alone.
Director interests (and their close families) are publicised information. Have you ever invested in a public company before?
Also, when you go to investor events, there's usually only about 20-30 people there. You get to speak to the BOD and they're quite open, funny that, they're normal, socially functioning human beings! On some occasions, their friends and family are stood with them! Shock, horror, at an investors event?!
Leave YOU alone? I'm trying to discuss the company I'm invested in. You're the one that's making it personal, you sh*t Hercule Poirot wannabe.
Ah, doubling down on the personal and not engaging with any of the actual company debate presented, the clear sign of someone that knows they've made themselves look a d*ck.
You know you're in the wrong. It's beautiful.
Stalker. Go bother someone else with your fantasy's of 26 million shares and spending £108k on an aim explorer.
I'm blocking you now. You can drivel on to someone else who may be in the slightest interested in your self aggrandising BS.
Hahaha, just read your message and tell me who's stalking who, you frigging weirdo. In the last 24 hours, you've made barely a post about the company and dozens about me, you nutjob.
I think realistically this company is going to fold. There's no positivity from the BOD of late. Utah isn't going to be a money spinner, time to sell a loss while you can.
In a couple of weeks time, we'll see half yearly results and sales progress and compare them against the Corporate Presentation and plan.
At that point we can make some informed assumptions.